ilomastat has been researched along with sb 3ct compound in 2 studies
| Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (sb 3ct compound) | Trials (sb 3ct compound) | Recent Studies (post-2010) (sb 3ct compound) |
|---|---|---|---|---|---|
| 103 | 0 | 45 | 74 | 0 | 49 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhikari, N; Baidya, SK; Banerjee, S; Jha, T | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for ilomastat and sb 3ct compound
| Article | Year |
|---|---|
Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery.
Topics: Drug Discovery; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases | 2022 |
1 other study(ies) available for ilomastat and sb 3ct compound
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |